The Shwartzman phenomenon is a rare condition that involves damage to small blood vessels. It was first observed in rabbits using a two-step process where an initial injection of an endotoxin primes the body and a second injection 24 hours later provokes a strong inflammatory reaction. This reaction causes acute inflammation, leading to intravascular coagulation (blood clotting inside the vessels), which in turn can cause capillary and venous thrombosis (narrowing or blockage of small veins) and tissue death (necrosis). The phenomenon highlights how the body’s immune reaction, blood clotting mechanism, and blood flow can interact, which means that its occurrence depends on a person’s overall immune system status and the state of their coagulation and fibrinolysis systems. It is noteworthy that while the original model required a two-step injection, similar events can occur with a single provoking exposure during infections or in the setting of pregnancy in other species.

Information about specific symptoms for people with this condition is limited. The condition involves hemorrhagic necrosis, which means there is bleeding and tissue death due to damage to small blood vessels. However, detailed descriptions of signs and symptoms in affected individuals are not well characterized.

The Shwartzman phenomenon is caused by an abnormal reaction to endotoxins. A priming exposure to endotoxins followed by a second exposure triggers an immune response that leads to severe inflammation and damage to the blood vessels. Factors such as a person’s immune system status, blood clotting processes, the body’s fibrinolysis, and blood flow all play a role in determining susceptibility. This reaction can also occur during certain infections or pregnancy.